Deutsche Bank’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-452,119
| Closed | -$836K | – | 4018 |
|
2023
Q1 | $836K | Buy |
452,119
+7,399
| +2% | +$13.7K | ﹤0.01% | 2204 |
|
2022
Q4 | $494K | Sell |
444,720
-62,686
| -12% | -$69.6K | ﹤0.01% | 2449 |
|
2022
Q3 | $1.19M | Buy |
507,406
+421,671
| +492% | +$986K | ﹤0.01% | 1869 |
|
2022
Q2 | $260K | Buy |
85,735
+4,878
| +6% | +$14.8K | ﹤0.01% | 2998 |
|
2022
Q1 | $549K | Buy |
80,857
+30,265
| +60% | +$205K | ﹤0.01% | 2679 |
|
2021
Q4 | $422K | Buy |
50,592
+31,635
| +167% | +$264K | ﹤0.01% | 2923 |
|
2021
Q3 | $141K | Sell |
18,957
-614
| -3% | -$4.57K | ﹤0.01% | 3698 |
|
2021
Q2 | $133K | Buy |
19,571
+8,355
| +74% | +$56.8K | ﹤0.01% | 3951 |
|
2021
Q1 | $115K | Sell |
11,216
-1,041
| -8% | -$10.7K | ﹤0.01% | 3852 |
|
2020
Q4 | $86K | Buy |
12,257
+3,475
| +40% | +$24.4K | ﹤0.01% | 3850 |
|
2020
Q3 | $72K | Buy |
8,782
+839
| +11% | +$6.88K | ﹤0.01% | 3644 |
|
2020
Q2 | $55K | Buy |
7,943
+1,252
| +19% | +$8.67K | ﹤0.01% | 3716 |
|
2020
Q1 | $32K | Sell |
6,691
-33,379
| -83% | -$160K | ﹤0.01% | 3659 |
|
2019
Q4 | $348K | Sell |
40,070
-43,492
| -52% | -$378K | ﹤0.01% | 2889 |
|
2019
Q3 | $277K | Sell |
83,562
-31,589
| -27% | -$105K | ﹤0.01% | 2963 |
|
2019
Q2 | $569K | Sell |
115,151
-47,701
| -29% | -$236K | ﹤0.01% | 3163 |
|
2019
Q1 | $1.01M | Buy |
162,852
+12,557
| +8% | +$77.7K | ﹤0.01% | 2967 |
|
2018
Q4 | $506K | Buy |
150,295
+40,282
| +37% | +$136K | ﹤0.01% | 3274 |
|
2018
Q3 | $716K | Buy |
110,013
+65,860
| +149% | +$429K | ﹤0.01% | 3520 |
|
2018
Q2 | $339K | Buy |
44,153
+17,917
| +68% | +$138K | ﹤0.01% | 3960 |
|
2018
Q1 | $585K | Sell |
26,236
-6,440
| -20% | -$144K | ﹤0.01% | 3560 |
|
2017
Q4 | $416K | Buy |
32,676
+11,805
| +57% | +$150K | ﹤0.01% | 3604 |
|
2017
Q3 | $323K | Buy |
20,871
+7,233
| +53% | +$112K | ﹤0.01% | 3530 |
|
2017
Q2 | $189K | Buy |
13,638
+5,542
| +68% | +$76.8K | ﹤0.01% | 3802 |
|
2017
Q1 | $177K | Buy |
+8,096
| New | +$177K | ﹤0.01% | 3502 |
|